Italy
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
32.26%
|
Dec. 31, 2023 | USD 2.00 | 0.87% |
|
Italy |
|
2 |
18.69%
|
Dec. 31, 2023 | USD 61.94 | 0.17% |
|
Italy |
|
3 |
13.92%
|
Dec. 31, 2023 | USD 106.08 | -0.85% |
|
Italy |
|
4 |
13.42%
|
Dec. 31, 2023 | USD 22.41 | 2.19% |
|
Italy |
|
5 |
12.70%
|
Dec. 31, 2023 | USD 54.52 | 1.77% |
|
Italy |
|
6 |
1.66%
|
Dec. 31, 2023 | USD 9.87 | -1.00% |
|
Italy |
|
7 |
-26.64%
|
Dec. 31, 2023 | USD 19.11 | -0.17% |
|
Italy |
|
8 |
-179.13%
|
Dec. 31, 2023 | USD 10.99 | 1.17% |
|
Italy |
The Healthcare company in Italy with the highest Net Income Margin is Arterra Bioscience (Milan Stock Exchange: ARBS.MI) at 32.26%.
The Healthcare company in Italy with the lowest Net Income Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -179.13%.
The top 10 Healthcare companies in Italy by Net Income Margin are Arterra Bioscience, Recordati Industria Chimica e Farmaceutica S.p.A., DiaSorin S.p.A., Stevanato Group S.p.A., Pharmanutra S.p.A., GPI S.p.A., Philogen S.p.A. and Newron Pharmaceuticals S.p.A..
The bottom 10 Healthcare companies in Italy by Net Income Margin are Newron Pharmaceuticals S.p.A., Philogen S.p.A., GPI S.p.A., Pharmanutra S.p.A., Stevanato Group S.p.A., DiaSorin S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A. and Arterra Bioscience.